Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MRPL53 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
mRNA | NIPSNAP3B | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
mRNA | DOLK | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-05 |
mRNA | TBPL1 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
mRNA | PRUNE1 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
mRNA | METTL18 | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
mRNA | RP11-201K10.3 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | EIF3E | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | YPEL4 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | HBB | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |